ALHC affiliate files Form 144 to sell 21,118 RSUs

ALHC affiliate filed a Form 144 to sell restricted stock units.

Accepted by SEC EDGAR 03/04/2026 - 04:41 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

ALHC affiliate filed a Form 144 to sell restricted stock units. The filing lists 21,118 restricted stock units associated with the issuer dated 03/13/2025. The filing also reports that Andreas Wagner sold 22,238 common shares on 02/10/2026 for $455,211.86.

Insights

Securities Attorney

Form 144 documents planned resale by an affiliate and a recent sale by an insider.

Form 144 lists 21,118 restricted stock units tied to the issuer with an effective date of 03/13/2025, indicating an affiliate intends to sell those securities under Rule 144 conditions.

The excerpt also records that Andreas Wagner completed a sale of 22,238 common shares on 02/10/2026 for $455,211.86. Timing, method, and any transfer restrictions are not detailed in the provided text; subsequent filings or broker confirmations would show settlement details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ALHC's Form 144 disclose about planned sales?

The Form 144 discloses 21,118 restricted stock units associated with the issuer, dated 03/13/2025. It indicates an affiliate has registered these units for potential resale under Rule 144 procedures.

Did an insider of ALHC recently sell shares?

Yes. The filing reports Andreas Wagner sold 22,238 common shares on 02/10/2026 for $455,211.86. The record shows the transaction and gross proceeds as listed.

What security types are included in the Form 144 for ALHC?

The filing lists restricted stock units for the issuer and common shares sold in the prior three months. The restricted stock units quantity is 21,118 and the recent sale involved common shares.

Who is the broker or dealer listed on the Form 144?

The broker-dealer listed is Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004, as shown in the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002006326
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ALIGNMENT HEALTHCARE INC
SEC File Number	001-40295
Address of Issuer	1100 W. Town and Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	8443102247
Name of Person for Whose Account the Securities are To Be Sold	ANDREAS WAGNER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21118	389627.10	204296493	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/13/2025	Restricted Stock Units	Issuer			21118	03/13/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREAS WAGNER 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	02/10/2026	22238	455211.86

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/13/2025 through 02/07/2026.
Date of Notice	03/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andreas Wagner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)